Article info

Download PDFPDF
Experimental therapeutics: preclinical
B06 Validation of KMO as a candidate therapeutic target for Huntington's disease in Drosophila melanogaster

Citation

Campesan S, Green EW, Sathyasaikumar KV, et al
B06 Validation of KMO as a candidate therapeutic target for Huntington's disease in Drosophila melanogaster

Publication history

  • First published November 16, 2010.
Online issue publication 
November 16, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.